Biotech

All Articles

Vaccine and Keytruda combo helpful in squamous tissue cancer

.Invulnerable checkpoint inhibitors are actually the superheroes of cancer cells therapy. Medication...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of substantial management hirings, firings and ...

Regeneron's Opdualag opponent presents 57% feedback fee

.Regeneron is back with lasting consequence for its LAG-3 inhibitor and also PD-1 prevention combo i...

AstraZeneca posts information on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has discussed a very early look at the functionality of its own internal antibody-drug ...

iTeos- GSK's TIGIT superstar reveals relevant improvement

.After declaring a phase 3 launch based upon good midstage outcomes, iTeos and GSK are actually even...

More collaborative FDA may accelerate rare condition R&ampD: file

.The FDA needs to be much more open and also collaborative to release a rise in commendations of unc...

Zenas, MBX, Bicara scalp to Nasdaq in warm day for biotech IPOs

.It's an unusually hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara Therap...

Atea's COVID antiviral fails to stop hospitalizations in phase 3

.Atea Pharmaceuticals' antiviral has actually neglected an additional COVID-19 trial, however the bi...

Neurocrine's quote to conserve mental illness possibility falls short

.Neurocrine Biosciences' schizophrenia system pivot has actually fallen short. The biotech was incap...

Sanofi pays for $110M upfront for late-stage radioligand therapy

.Sanofi has made a late access to the radioligand party, paying one hundred thousand euros ($ 110 mi...